Cure8 news brief
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.
This South American study explores whether Amerindian ancestry and known genetic variants relate to clinical outcomes in Crohn’s and ulcerative colitis, which could affect risk prediction and understanding of disease variability.
Researchers studying IBD genetics, clinicians interested in population differences in IBD presentation, and patients or advocates from underrepresented ancestry groups curious about genetic research relevance.
The research enrolled IBD patients and controls at a tertiary hospital in Santiago, Chile, collected detailed clinical and endoscopic data, and genotyped participants using a genome-wide array.
The team assessed ancestry proportions, examined previously reported IBD risk variants, and applied machine-learning approaches to develop predictive models for clinical phenotypes and outcomes.
The paper emphasizes that ancestrally diverse populations have been underrepresented in IBD genetics research and that incorporating non-European ancestry may improve prediction of risk or disease course.
The study is observational and focused on associations between ancestry/genetic markers and clinical measures (e.g., remission, relapse, surgeries, medication history), not on testing new treatments.
Findings are from an observational cohort genotyped with a commercial array and analyzed with statistical and machine-learning methods. The study identifies associations and predictive modeling efforts but does not test interventions. Results require replication in larger and multi-center cohorts before changing clinical practice.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
If hospital-treated infections raise later IBD risk—especially in people with certain immune-related genetic variants—this supports a multi-hit model of IBD and could eventually help identify higher-risk individuals...
A test that more accurately predicts which IBD patients with pre-cancerous bowel changes will develop cancer could help target surveillance and treatment to those at higher risk and reduce unnecessary procedures for...
This research suggests genetic risk scores could help identify people with IBD who are more likely to have severe disease, which might eventually inform earlier monitoring or treatment decisions. It’s a step toward more...
